| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 10/12/2006 | CA2602228A1 Triamine derivative |
| 10/12/2006 | CA2602025A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1709048A2 Method of preparing porphyrin derivatives, porphyrin derivatives, uses thereof and pharmaceutical compositions |
| 10/11/2006 | EP1709047A2 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 10/11/2006 | EP1709046A1 P38 kinase inhibitors |
| 10/11/2006 | EP1709045A1 Naphthyridine derivatives and their use as modulators of muscarinic receptors |
| 10/11/2006 | EP1709044A2 Oxazolidinone-quinolone hybrid antibiotics |
| 10/11/2006 | EP1709043A1 Pyrrolopyridine-substituted benzol derivatives for treating cardiovascular diseases |
| 10/11/2006 | EP1709037A2 Hiv protease inhibiting sulfonamides |
| 10/11/2006 | EP1709006A1 Benzimidazole derivatives |
| 10/11/2006 | EP1708701A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 10/11/2006 | EP1708697A2 Chemical compounds |
| 10/11/2006 | EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 10/11/2006 | EP1107959B1 Quinazoline derivatives as medicaments |
| 10/11/2006 | EP0944619B1 Novel integrin receptor antagonists |
| 10/11/2006 | CN1845922A Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 10/11/2006 | CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors |
| 10/11/2006 | CN1845908A 5-substituted quinazolinone derivatives |
| 10/11/2006 | CN1279044C Non-steroidal progesterone receptor modulators |
| 10/11/2006 | CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 10/11/2006 | CN1279034C Dna－pk抑制剂 Dna-pk inhibitors |
| 10/10/2006 | US7119207 NK-1 receptor antagonists, (e.g., substance P receptor antagonists) |
| 10/10/2006 | US7119205 Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
| 10/10/2006 | US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/10/2006 | US7119199 Process for the preparation of pyridopyrimidones |
| 10/10/2006 | US7119196 Anxiolytic agents with reduced sedative and ataxic effects |
| 10/10/2006 | US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119095 Pharmaceutically active compounds and methods of use thereof |
| 10/10/2006 | US7119091 Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient |
| 10/10/2006 | US7119080 Boronic ester and acid compounds, synthesis and uses |
| 10/10/2006 | US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same |
| 10/10/2006 | CA2535742C Preparation of risperidone |
| 10/10/2006 | CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 10/10/2006 | CA2113623C Use of quinolizine derivatives as orexigenics |
| 10/05/2006 | WO2006105289A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | WO2006105063A1 Heterobicylic inhibitors of tgfbeta |
| 10/05/2006 | WO2006104971A1 Atp competitive kinase inhibitors |
| 10/05/2006 | WO2006104915A2 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS |
| 10/05/2006 | WO2006104406A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 10/05/2006 | WO2006104356A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 10/05/2006 | WO2006104161A1 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-Met AUTOPHOSPHORYLATION INHIBITING POTENCY |
| 10/05/2006 | WO2006103559A1 Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
| 10/05/2006 | WO2006103255A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | WO2006090273A3 [1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia |
| 10/05/2006 | WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 10/05/2006 | WO2006068826A3 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
| 10/05/2006 | WO2006015124A3 Fused ring heterocycle kinase modulators |
| 10/05/2006 | WO2005115392A8 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 10/05/2006 | WO2005103050A3 Azaindoles useful as inhibitors of rock and other protein kinases |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223993 Colorant compounds, intermediates, and compositions |
| 10/05/2006 | US20060223860 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223859 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223858 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223850 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 10/05/2006 | US20060223844 Mitotic kinesin inhibitors |
| 10/05/2006 | US20060223843 Substituted 1,5-naphthyridine azolinones |
| 10/05/2006 | US20060223842 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia |
| 10/05/2006 | US20060223836 New phenylalanine derivatives |
| 10/05/2006 | US20060223832 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/05/2006 | US20060223810 2,3-Dihydro-benzo[1,4]dioxine-6-carboxylic acid [2-(6-methoxy-quinolin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]-amide |
| 10/05/2006 | US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics |
| 10/05/2006 | CA2603322A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | CA2603125A1 Thienopyridine derivative, quinoline derivatives,and quinazoline derivatives, having c-met autophosphorylation inhibiting activity |
| 10/05/2006 | CA2603122A1 Phenyl and pyridyl lta4h modulators |
| 10/05/2006 | CA2603088A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 10/05/2006 | CA2603049A1 Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
| 10/05/2006 | CA2602553A1 2,4,8-trisubstituted 8h-pyrido[2,3-d]pyrimidin-7-one derivatives, compositions thereof, and uses thereof |
| 10/05/2006 | CA2602284A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/04/2006 | EP1707566A1 Deazapurines and uses thereof |
| 10/04/2006 | EP1706412A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
| 10/04/2006 | EP1706404A2 Tetrahydrocarboline compounds as anticancer agents |
| 10/04/2006 | EP1706403A2 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 10/04/2006 | EP1706391A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-&(k)beta activity and use thereof |
| 10/04/2006 | EP1706384A1 Therapeutic agents i |
| 10/04/2006 | EP1513840B1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 10/04/2006 | EP1414912B1 Perylene pigment compositions |
| 10/04/2006 | EP1406900B1 Novel compounds, their preparation and use |
| 10/04/2006 | EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 10/04/2006 | CN1842529A Compounds and compositions as protein kinase inhibitors |
| 10/04/2006 | CN1842510A Fluorene-based derivative and organic electroluminescence device employing the same |
| 10/04/2006 | CN1842336A Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 10/04/2006 | CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115744 Method for producing 8-methoxy-quinolinecarboxylic acids |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115644 Antiinflammatory agents; osteoarthritic; antihistamines; multiple sclerosis; antiulcer agents; skin disorders; graft versus host disease; abtidiabetic agents; Alzheimer's disease; antidiabetic agents |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
| 10/03/2006 | US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115622 Amido ether substituted imidazoquinolines |
| 10/03/2006 | US7115621 Chemical compounds |
| 10/03/2006 | US7115619 N8, N13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |